Vali Nanomedical is a company that is known for their technology platform that was developed to create a multi-drug delivery system. The company was founded by Andrew Gray in 2013, in San Francisco, California, United States.
The company is primarily focused on developing programmable delivery systems for therapeutics and imaging agents. In order to create their platform and to help solve delivery problems, Vali Nanomedical has partnered with other pharmaceutical companies. A novel imaging agent designed for use in basic research and clinical diagnostics was the result. Their mission is to eventually cure diseases without the use of drugs.
One of Vali's technologies can be used to reprogram cancerous cells, forcing them to commit suicide, which allows healthier cells to expand and repopulate where cancer cells resided.
Some of the pharmaceutical and biotechnology companies that Vali has partnered with includes Geltor, Memphis Meats, Jungla Inc., The Not Company, Ember Medical, BioAesthetics, BioROSA Technologies Inc., Koniku Inc., New Age Meats, NovoNutrients, Endless West, Finless Foods, Health Linkages, QuantumCyte, Quartolio, Sugarlogix, Chronus Health, Clara Foods, NURO Corp, Prellis Biologics, and many more.